Voglibite-GM 2/0.3 Tablet SR
Marketer
Corona Remedies Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Voglibite-GM 2/0.3 Tablet SR
Diabex Duo 2/0.3mg Extended-Release Tablets are classified as anti-diabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular meals and carry readily-available glucose sources like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Voglibite-GM 2/0.3 Tablet SR
No text provided to rephrase.
Uses of Voglibite-GM 2/0.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Voglibite-GM 2/0.3 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglibite-GM 2/0.3 Tablet SR on an empty stomach.
Common Side effects of Voglibite-GM 2/0.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglibite-GM 2/0.3 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglibite-GM 2/0.3 Tablet SR on an empty stomach.
How Voglibite-GM 2/0.3 Tablet SR works:
Voglibite-GM 2/0.3 extended-release tablets contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglibite-GM 2/0.3 Tablet SR and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Voglibite-GM 2/0.3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Voglibite-GM 2/0.3mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Voglibite-GM 2/0.3 SR tablets are likely unsafe for individuals with kidney impairment and should be omitted. Seek medical advice before use. The use of Voglibite-GM 2/0.3 SR tablets is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Voglibite-GM 2/0.3 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, Voglibite-GM 2/0.3 Tablet SR therapy typically begins with a reduced dose; however, it's contraindicated in those with severe hepatic dysfunction.
What if you forget to take Voglibite-GM 2/0.3 Tablet SR :
Should you forget a Voglibite-GM 2/0.3 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Voglibite-GM 2/0.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently